Latest News

Real-World Data Support Effectiveness of Neffy (epinephrine nasal spray) for Acute Treatment of Anaphylaxis / image courtesy of ARS pharmaceuticals
Real-World Data Support Effectiveness of Neffy (epinephrine nasal spray) for Acute Treatment of Anaphylaxis

September 15th 2025

A single dose of neffy was effective in nearly 90% of patients treated for anaphylactic reactions during oral food challenge and allergen immunotherapy.

t Intranasal Epinephrine Should Be Prescribed with Confidence, Editorial Encourages / image credit ©kalpis/stock.adobe.com
Intranasal Epinephrine Should Be Prescribed with Confidence, Editorial Encourages

July 25th 2025

Needle-Free Epinephrine Nasal Spray Shows Promise in Pediatric Food Allergy Anaphylaxis
Needle-Free Epinephrine Nasal Spray Shows Promise in Pediatric Food Allergy Anaphylaxis

July 21st 2025

FDA Accepts NDA for Anaphylm™, a Sublingual Epinephrine Film for Treatment of Severe Allergic Reactions
FDA Accepts NDA for Anaphylm™, a Sublingual Epinephrine Film for Treatment of Severe Allergic Reactions

June 17th 2025

Study of Intranasal Epinephrine Powder (NS002) Published in Prestigious International Journal, Nasus Pharma Ltd Says / image credit ©MQ-Illustrations/stock.adobe.com
Phase 2 Dose-Finding Study of Intranasal Epinephrine Powder (NS002) Supports Development for Regulatory Submission

June 3rd 2025

Latest CME Events & Activities
© 2025 MJH Life Sciences

All rights reserved.